Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

MOR-208 receives FDA and EMA orphan drug designations

May 21, 2014

ADC Therapeutics and MedImmune to advance ADCT-401 into clinic

May 21, 2014

NeoStem signs licensing agreement with Cellular Biomedicine for DC-TC

May 20, 2014

Helix BioPharma seeks Canadian clearance for study of L-DOS47

May 15, 2014

FDA grants nivolumab breakthrough therapy designation for Hodgkin's lymphoma

May 15, 2014

FDA grants fast track status to Prima BioMed's CVac program

May 12, 2014

Cellmid selects lead anti-MK antibody in oncology

May 12, 2014

PSMA MAb [177Lu]J-591 tested for treatment of metastatic solid tumors

May 12, 2014

New anticancer agents patented by Chinese scientists

May 9, 2014

Mologen files clinical trial applications for phase III trial of anticancer immunostimulant

May 8, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026